Medications Current medication   66423-5

LOINC Code


LOINC code66423-5
nameMedications Current medication
statusACTIVE

Fully-Specified Name

componentMedications
propertyFind  =  Finding
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
systemMedication.current
scaleNom  =  Nominal:  Nominal or categorical responses that do not have a natural ordering. (e.g., names of bacteria, reported as answers, categories of appearance that do not have a natural ordering, such as, yellow, clear, bloody.
method

Additional Names

short nameMedications Medication.current

Basic Attributes

classPHENX
type2  Clinical
order vs. observationObservation

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Panels

66150-4Over the counter medications
66149-6Prescribed medications

History/Usage

first released
last updated2.74
last change typeMAJ  - change to name field other than Component;
change reasonRelease 2.74: METHOD_TYP: Removed Method as this concept is not specific to PhenX; Status: Moved from Trial to Active for increased usability; Previous Releases: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

Related Names

Finding
Findings
Med
Nominal
PhenX
Point in time
Random

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.